Hematologic Responses Achieved with Luspatercept in Higher-Risk Myelodysplastic Syndromes. - Leonard D; Sallman DA; Pugh K; Bell C; Al Ali NH; Borate U; Komrokji RS; Brunner AM (Blood advances, 2026)